Related Experiment Video
Updated: May 10, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Recurrent contact granuloma: experience with excision and botulinum toxin injection
Taner Yilmaz1, Nilda Süslü, Gamze Atay
1Department of Otolaryngology, Hacettepe University, Faculty of Medicine, 06100 Sıhhiye, Ankara, Turkey. tyilmaz@hacettepe.edu.tr
Importance:
Contact granuloma is a difficult-to-treat laryngeal disorder associated with vocal abuse, habitual throat clearing, and laryngopharyngeal reflux. It has a high propensity for persistence and recurrence despite many treatment alternatives.
Objective:
To present our experience with recurrent contact granuloma treated with microlaryngoscopic excision and botulinum toxin injection.
Design:
Case series. The follow-up period had a mean (range) of 41 (11-88) months.
Setting:
Tertiary referral university clinic.
Participants:
Twenty patients with recurrent, grade 3 and grade 4 contact granuloma whose lesion was excised at least once after failure of conservative treatments.
Interventions:
Microlaryngoscopic excision and botulinum toxin type A injection into the region of the bilateral thyroarytenoid and lateral cricoarytenoid muscles.
Main Outcomes And Measures:
Disappearance of contact granuloma.
Results:
Seventeen patients were cured of their contact granuloma. Three patients experienced recurrences: 2 received botulinum toxin injection only as outpatients and recovered. The other patient required reexcision and reinjection under general anesthesia. These 3 patients were free of granuloma at their last follow-up.
Conclusions And Relevance:
After failed conservative treatment, microlaryngoscopic excision and botulinum toxin type A injection is successful in the treatment of recurrent contact granuloma. Removing recurrent granulomas can result in a low recurrence rate if botulinum toxin type A is added at the time of removal.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
